A
Anuradha Lala
Researcher at Icahn School of Medicine at Mount Sinai
Publications - 155
Citations - 6472
Anuradha Lala is an academic researcher from Icahn School of Medicine at Mount Sinai. The author has contributed to research in topics: Medicine & Heart failure. The author has an hindex of 31, co-authored 112 publications receiving 3528 citations. Previous affiliations of Anuradha Lala include Cardiovascular Institute of the South & Brigham and Women's Hospital.
Papers
More filters
Journal ArticleDOI
Association of Treatment Dose Anticoagulation With In-Hospital Survival Among Hospitalized Patients With COVID-19.
Ishan Paranjpe,Valentin Fuster,Anuradha Lala,Adam Russak,Adam Russak,Benjamin S. Glicksberg,Benjamin S. Glicksberg,Matthew A. Levin,Alexander W. Charney,Jagat Narula,Zahi A. Fayad,Emilia Bagiella,Shan Zhao,Shan Zhao,Girish N. Nadkarni +14 more
TL;DR: The novel coronavirus disease-2019 (COVID-19) has affected nearly every country worldwide and there are anecdotal observations of improved outcomes with systemic anticoagulation (AC), however, the specific outcomes are still unclear.
Journal ArticleDOI
Prevalence and Impact of Myocardial Injury in Patients Hospitalized With COVID-19 Infection.
Anuradha Lala,Anuradha Lala,Kipp W. Johnson,James L. Januzzi,Adam Russak,Ishan Paranjpe,Felix Richter,Shan Zhao,Sulaiman Somani,Tielman Van Vleck,Akhil Vaid,Fayzan Chaudhry,Jessica K De Freitas,Zahi A. Fayad,Sean Pinney,Matthew A. Levin,Alexander W. Charney,Emilia Bagiella,Jagat Narula,Benjamin S. Glicksberg,Girish N. Nadkarni,Donna M. Mancini,Valentin Fuster +22 more
TL;DR: Cardiovascular disease (CVD) including coronary artery disease, atrial fibrillation, and heart failure, was more prevalent in patients with higher troponin concentrations, as were hypertension and diabetes.
Journal ArticleDOI
Anticoagulation, Bleeding, Mortality, and Pathology in Hospitalized Patients With COVID-19.
Girish N. Nadkarni,Anuradha Lala,Emilia Bagiella,Helena L. Chang,Pedro R. Moreno,Elisabet Pujadas,Varun Arvind,Sonali Bose,Alexander W. Charney,Martin D. Chen,Carlos Cordon-Cardo,Andrew Dunn,Michael E. Farkouh,Benjamin S. Glicksberg,Arash Kia,Roopa Kohli-Seth,Matthew A. Levin,Prem Timsina,Shan Zhao,Zahi A. Fayad,Valentin Fuster +20 more
TL;DR: Association of AC with in-hospital outcomes and thromboembolic findings on autopsies was associated with lower mortality and intubation among hospitalized COVID-19 patients, although not statistically significant.
Journal ArticleDOI
AKI in hospitalized patients with COVID-19
Lili Chan,Kumardeep Chaudhary,Aparna Saha,Kinsuk Chauhan,Akhil Vaid,Shan Zhao,Ishan Paranjpe,Sulaiman Somani,Felix Richter,Riccardo Miotto,Anuradha Lala,Arash Kia,Prem Timsina,Li Li,Robert Freeman,Rong Chen,Jagat Narula,Allan C. Just,Carol R. Horowitz,Zahi A. Fayad,Carlos Cordon-Cardo,Eric E. Schadt,Matthew A. Levin,David Reich,Valentin Fuster,Barbara Murphy,John Cijiang He,Alexander W. Charney,Erwin P. Bottinger,Benjamin S. Glicksberg,Steven G. Coca,Girish N. Nadkarni +31 more
TL;DR: This retrospective, observational study involved a review of data from electronic health records of patients aged ≥18 years with laboratory-confirmed COVID-19 admitted to the Mount Sinai Health System from February 27 to May 30, 2020 to describe the frequency of AKI and dialysis requirement, AKI recovery, and adjusted odds ratios with mortality.
Journal ArticleDOI
COVID-19 in solid organ transplant: A multi-center cohort study.
Olivia S Kates,Brandy Haydel,Sander Florman,Meenakshi Rana,Zohra S Chaudhry,Mayur Ramesh,Kassem Safa,Camille N. Kotton,Emily A. Blumberg,Behdad Besharatian,Sajal D Tanna,Michael G. Ison,Maricar Malinis,Marwan M. Azar,Robert M. Rakita,Jose A Morillas,Aneela Majeed,Afrah S Sait,Mario Spaggiari,Vagish Hemmige,Sapna A. Mehta,Henry J Neumann,Abbasali Badami,Jason D Goldman,Anuradha Lala,Marion Hemmersbach-Miller,Margaret E McCort,Valida Bajrovic,Carlos Ortiz-Bautista,Rachel J. Friedman-Moraco,Sameep Sehgal,Erika D. Lease,Cynthia E. Fisher,Ajit P. Limaye,UW Covid Sot Study Team +34 more
TL;DR: Age and underlying comorbidities rather than immunosuppression intensity-related measures were major drivers of mortality among SOT recipients hospitalized for COVID-19, and multiple measures of immunosppression intensity were not associated with mortality.